Want to see HK:9989 full AI Analyst Report?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Ownership - Who Owns Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H?
2 Followers
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Ownership Overview
- 0.50% Mutual Funds
- 0.48% ETFs
- 99.02% Public Companies and Individual Investors
The ownership structure of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is a mix of institutional, retail, and individual investors. Approximately 0.98% of the company’s stock is owned by Institutional Investors, and 99.02% is owned by Public Companies and Individual Investors.
The ownership structure of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is a mix of institutional, retail, and individual investors. Approximately 0.98% of the company’s stock is owned by Institutional Investors, and 99.02% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dfa Investment Dimensions Group Inc | 1,065,000 | Institution | 0.48% | 547,410 |
| Vanguard | 661,500 | Institution | 0.30% | 340,011 |
| Dimensional | 395,000 | Institution | 0.18% | 203,030 |
| Vanguard Star Funds | 20,000 | Institution | <0.01% | 10,280 |
| Vanguard International Equity Index Funds | 15,500 | Institution | <0.01% | 7,967 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dfa Investment Dimensions Group Inc | 1,065,000 | Institution | 0.48% | 547,410 |
| Vanguard Star Funds | 20,000 | Institution | <0.01% | 10,280 |
| Vanguard International Equity Index Funds | 15,500 | Institution | <0.01% | 7,967 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dimensional, DFEM ETF | 225,000 | Institution | 0.10% | 114,419 |
| Dimensional, DFAX ETF | 94,500 | Institution | 0.04% | 48,056 |
| Dimensional, DFEV ETF | 75,500 | Institution | 0.03% | 38,394 |
| Vanguard, VXUS ETF | 20,000 | Institution | <0.01% | 10,312 |
| Vanguard, VT ETF | 15,500 | Institution | <0.01% | 7,992 |
FAQ
What percentage of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.98% of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is held by institutional investors: 0.50% by mutual funds and 0.48% by ETFs.
What percentage of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.02% of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is held by public companies and individual investors.
Who owns the most shares of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)?
DFA INVESTMENT DIMENSIONS GROUP INC owns the most shares of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
